Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study

Nobutaka Hattori, Masahiro Nomoto, Yuji Sasagawa et al.|Parkinsonism & Related Disorders|2020

Cited by 80